| Country Patient Safety Head - France |
Paris Headquarter (Novartis Pharma S.A.S.) |
Frankreich |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Sales Representative (d/w/m), Rheumatologie,Gebiet: Südhessen |
Hessen (Novartis Pharma GmbH) |
Deutschland |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| Senior Expert Technical Development- Drug Product Project Lead |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Vendor Alliance Lead Associate Director (Remote) |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Associate Director, M&A Planning & Integration |
East Hanover |
USA |
Finance |
Corporate |
Audit und Finanzen |
17. Oktober 2024 |
| Senior Specialist DDIT ISC Detection & Response |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Technology Transformation |
17. Oktober 2024 |
| Production Technician I |
Millburn |
USA |
Operations |
Innovative Medicines |
Technical Operations |
17. Oktober 2024 |
| Sr. Specialist DDIT ISC Detection & Response |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Technology Transformation |
17. Oktober 2024 |
| Laboratorijski analitik (m/ž/d) |
Ljubljana |
Slowenien |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| Specialist kontrole kakovosti (m/ž/d) |
Ljubljana |
Slowenien |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| AS&T specialist (m/ž/d) |
Ljubljana |
Slowenien |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| MR |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| AD, Access & Reimbursement - Minneapolis - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
17. Oktober 2024 |
| Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
17. Oktober 2024 |
| Global Program Safety Lead - Immunology |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Global Program Safety Lead - Immunology |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Sandoz |
Research & Development |
17. Oktober 2024 |
| Vice President, Head of R&D Legal, Americas |
Cambridge (USA) |
USA |
Legal |
Corporate |
Legal & Intellectual Property & Compliance |
17. Oktober 2024 |
| Executive Director, R&D Legal and FDA Regulatory Legal Lead |
East Hanover |
USA |
Legal |
Corporate |
Legal & Intellectual Property & Compliance |
17. Oktober 2024 |
| Site Head – Biomedical Research India |
Hyderabad (Office) |
Indien |
Biomedical Research |
Pharma Research |
Research & Development |
17. Oktober 2024 |
| Interim HR System Expert |
Milano |
Italien |
People & Organization |
CTS |
Humanressourcen |
17. Oktober 2024 |
| Strategy Director, Clinical Development |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Patient Support - Manager, Program Operations Management |
East Hanover |
USA |
US |
Innovative Medicines |
Marketing |
17. Oktober 2024 |
| Access & Reimbursement Manager NPS - Enterprise - Rocky Mountains - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| Associate Director, Integrated Insights, New Products, Oncology |
East Hanover |
USA |
US |
Innovative Medicines |
Marketing |
17. Oktober 2024 |
| Medical Science Liaison (MSL) ONC Solid Tumor Chicago Territory Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Access & Reimbursement Manager NPS - Enterprise - Great Lakes - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| Senior Clinical Research Associate (Remote) |
Field Non-Sales (USA) |
USA |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| (高级)大区经理 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| Digital Quality Control specialist |
INSURGENTES |
Mexiko |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| Compliance & Quality System Manager |
Ivrea |
Italien |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| MR |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| Compliance & Quality System Manager |
Ivrea |
Italien |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| MR |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Taiyuan (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Haikou (Hainan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| MR |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| Compliance & Quality System Manager |
Ivrea |
Italien |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| MR |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| Compliance & Quality System Manager |
Ivrea |
Italien |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| MR |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| Compliance & Quality System Manager |
Ivrea |
Italien |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| MR |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| Compliance & Quality System Manager |
Ivrea |
Italien |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| MR |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| Compliance & Quality System Manager |
Ivrea |
Italien |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| MR |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| Compliance & Quality System Manager |
Ivrea |
Italien |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| MR |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |
| Compliance & Quality System Manager |
Ivrea |
Italien |
Operations |
Innovative Medicines |
Quality |
17. Oktober 2024 |
| (高级)医药代表 /(资深)产品专员 |
Eerduosi (Neimenggu Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
17. Oktober 2024 |